Guillaume Feugray Selected Research

Guillaume Feugray Research Topics

3	Hemorrhage 02/2022 - 10/2020
1	Heavy Chain Disease 10/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2022
1	Inflammation (Inflammations) 02/2022
1	Thrombosis (Thrombus) 02/2022
1	Factor XII Deficiency 02/2022
1	Hemophilia A (Haemophilia) 02/2022
1	Hemolysis 01/2022
1	Factor XI Deficiency (Hemophilia C) 12/2021
1	Heart Failure 11/2021
1	Hypertension (High Blood Pressure) 11/2021
1	Pulmonary Hypertension 11/2021
1	Hypoxia (Hypoxemia) 11/2021
1	COVID-19 01/2021
1	Clinical Deterioration 01/2021
1	Factor V Deficiency 10/2020
1	Hepatolenticular Degeneration (Wilson's Disease) 01/2020
1	Infections 01/2019
1	Polycythemia (Erythrocytosis) 01/2019
1	Fungemia 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019
1	Trichosporonosis 01/2019

3	Thrombin FDA Link 02/2022 - 10/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 10/2022
1	Blood Coagulation Factors (Coagulation Factor)IBA 02/2022
1	Factor VIII (Coagulation Factor VIII)IBA 02/2022
1	Factor XII (Hageman Factor)IBA 02/2022
1	Angiotensin IIIBA 11/2021
1	LysophospholipidsIBA 11/2021
1	CopperIBA 01/2020
1	Voriconazole (Vfend)FDA LinkGeneric 01/2019
1	isavuconazoleIBA 01/2019
1	AzolesIBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	PolyenesIBA 01/2019
1	EchinocandinsIBA 01/2019
1	hemoglobin Saint NazaireIBA 01/2019

1	Therapeutics 01/2019